BioCatalyst

PCV21, 20vPCV — catalyst calendar

2 verified catalyst event(s) referencing PCV21, 20vPCV, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-01
in 2mo
ESTIMATED
 READOUT
Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent
Phase 3 · Pneumococcal Infections
 SNY Sanofi PCV21, 20vPCV ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2027-01-07
in 4mo
ESTIMATED
 READOUT
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children
Phase 3 · Sickle Cell Disease
 SNY Sanofi PCV21, 20vPCV ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.